Physician

Mamoun I Najjar, MD

According to 2025 Medicare claims, Mamoun Najjar, MD (NPI: 1043269061) practices internal medicine in the Decatur, AL market, with the plurality of this provider's patient population coming from Morgan, AL. This provider's primary affiliated billing organization is SLEEP & PULMONARY CARE CENTER, P.C. (NPI: 1346406469; TIN: 26-3065690) and primary practice location at 35601-4351.

Najjar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 350 traditional Medicare patients, billed 2,257 HCPCS/CPT codes, and received $210,168 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,509 prescription claims across 236 beneficiaries totaling $362,935 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,517 claims. Open Payments data shows 34 records totaling $776. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $744,259 to $210,168. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $821,303 and ending at $362,935. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $395,611 to $60,609.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	924	6,769	$744,259
2016	965	6,720	$699,781
2017	810	8,347	$567,144
2018	874	5,484	$545,946
2019	732	4,388	$447,753
2020	621	3,504	$364,933
2021	517	3,147	$316,790
2022	385	2,678	$263,086
2023	323	2,214	$205,368
2024	350	2,257	$210,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	486	3,832	$821,303
2016	388	2,680	$591,500
2017	334	2,311	$528,497
2018	242	1,220	$228,008
2019	136	622	$95,216
2020	165	780	$151,301
2021	328	2,204	$585,537
2022	301	2,509	$875,926
2023	254	1,520	$455,320
2024	236	1,509	$362,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,280	6,033	$408,772
2016	1,811	5,343	$247,510
2017	1,441	3,779	$136,764
2018	1,498	3,806	$156,855
2019	1,175	3,295	$129,998
2020	1,002	2,737	$124,861
2021	725	2,188	$100,167
2022	514	1,496	$70,294
2023	517	1,499	$90,948
2024	567	1,517	$77,394

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	142	551	$85
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	176	$84
94729	Test to examine how well the lungs exchange gases	139	159	$28
94726	Test to determine lung volumes using sensors	138	158	$28
94060	Test to measure expiratory airflow and volume changes before and after medication administration	139	159	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	273	9,030	$189,833
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	92	3,060	$63,958
Roflumilast	Roflumilast	220	8,090	$13,048
Symbicort	Budesonide/Formoterol Fumarate	34	1,590	$11,323
Spiriva Respimat	Tiotropium Bromide	12	660	$8,269

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	28	125	$10,820
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	20	143	$10,186
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,014
A7030	Full face mask used with positive airway pressure device, each	N	37	69	$5,461
A7031	Face mask interface, replacement for full face mask, each	N	34	80	$5,268

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$776	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mamoun I. Najjar, MD?

Tedicare shows public-source Medicare data for Mamoun I. Najjar, MD (NPI 1043269061), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mamoun I. Najjar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mamoun I. Najjar, MD?

Mamoun I. Najjar, MD is linked to SLEEP & PULMONARY CARE CENTER, P.C. (billing NPI 1346406469) in the available physician profile data.

Does Mamoun I. Najjar, MD have Open Payments data?

Mamoun I. Najjar, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.